Old Web
English
Sign In
Acemap
>
Paper
>
Dosimetry and optimal time frame of [18F]SiTATE PET/CT in Patients with Neuroendocrine Carcinoma
Dosimetry and optimal time frame of [18F]SiTATE PET/CT in Patients with Neuroendocrine Carcinoma
2021
Leonie Beyer
A Gosewisch
S Lindner
F. Volter
LM Mittlmeier
R. Tiling
CC Cyran
M Unterrainer
J. Rübenthaler
C.J. Auernhammer
C. Spitzweg
Guido Böning
Franz-Josef Gildehaus
K Jurkschaft
Carmen Wängler
B Waengler
Ralf Schirrmacher
A Todica
P. Bartenstein
H. İlhan
Keywords:
PET-CT
Nuclear medicine
Frame (networking)
neuroendocrine carcinoma
in patient
time optimal
Dosimetry
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]